Prevalence and Risk Factors for Hepatitis C Virus Infection in Hemodialysis Pateints in Sulaimani

Authors

  • Zhian Salah Ramzi Department of Family and Community Medicine, College of Medicine, Sulaimani University, Sulaimani, Iraq
  • Aras Aziz Abdulla Department of Medicine, College of Medicine, Sulaimani University, Sulaimani, Iraq
  • Tariq AL-Hadithi Department of Community Medicine, College of Medicine, Hawler Medical University, Erbil, Iraq
  • Namir G. Al-Tawil Department of Community Medicine, College of Medicine, Hawler Medical University, Erbil, Iraq

Keywords:

Hepatitis C, Sulaimani, hemodialysis, prevalence

Abstract

Background and Objectives: Haemodialysis patients have an increased risk of exposure to hepatitis C virus (HCV) infection. A high prevalence of HCV infection in hemodialysis (HD) patients has been reported. The study was carried out to determine the prevalence of HCV infection among HD patients and its association with certain socio-demographic variables and risk factors in Sulaimani governorate.

Material and Methods: A total of 101 patients on hemodialysis in sulaimani dialysis unit were studied from 1st October to 31st of December 2009. All study subjects were screened for anti- HCV antibody by third generation ELISA and confirmed by RIBA 111. Soci-demographic data and Factors that might be implicated in HCV transmission were collected.

Results: The overall prevalence of HCV was 26.7%. A significant association of anti- HCV with dialysis duration, history of blood transfusion, number of transfused blood units was found.

Conclusions: HCV is common among Sulaimani hemodialysis patients, and significantly associated with length of dialysis and number of transfused blood units. The use of separate machines for those who are anti-HCV positive should be emphasized.

Metrics

Metrics Loading ...

References

Stechman-breen CO, Emerson S, Gretch D, Johnson RJ. Risk of death among chronic dialysis patients infected with hepatitis C virus. Am J Kidney Dis 1998; 32:629-34.

Huraib S, Al-Rashed R, Aldrees A, Aljefry N, Arif M, Al-Faleh FA. High prevalence of and risk factors for hepatitis C in haemodialysis patients in Saudi Arabia: a need for new dialysis strategies. Nephrol Dial Transplant 1995; 10( 4):470-4.

Yilmaz ME, Kara IH, Sari Y, Duzen S, Usul Y, Iskoglu B. Seroprevalence and risk factors of HCV in dialysis patients in a university haemodialysis center of southeast Anatolia, Turkey. Dial Transplant 2001; 30: 748-55.

Othman BM, Monem FS. Prevalence of hepatitis C antibodies among health care workers in Damascus, Syria. Saudi Med J 2001; 22( 7): 603- 5.

Alavian SM, Hosseini- Moghaddam SM, Rahnavardi M. Hepatitis among hemodialysis patients: An epidemiologic, diagnostic, and therapeutic. Hep Month 2007; 7( 3): 153-62.

Said RA, Hamzeh YY, Mehyar NS, Rababah MS. Hepatitis C virus infection in hemodialysis patients in Jordan. Saudi Med J 2003; 24( 7): S 137.

Abdel- Aziz F, Habib M, Mohaned MK, Abdel- Hamid M, Gamil F, Madkour S,et al. Hepatitis c virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence. Hepatology 2000; 2( 1): 111-5.

Jaiswal SK, Chitnis DS, Salgia P, Sepaha A, Pandit CS. Prevalence of hepatitis viruses among chronic renal failure patients on haemodialysis in Central India. Dial Transplant 2002; 31: 234-40.

Lin DY, Lin HH, Huang CC, Liaw YF. High incidence of hepatitis C virus infection in hemodialysis patients in Taiwan. Am J Kidney Dis 1993; 21(3):288-91.

Mendez-Sanchez N, Motola-Kuba D, Chavez-Tapia NC, Bahena J, Correa-Rotter R, Uribe M. Prevalence of hepatitis C vitus infection among hemodialysis patients at a tertiary-care hospital in Mexico city. Mexico. J of Clin Microbiol 2004; 42( 9): 4321-2.

Jadoul M, Poignet JL, Geddes C, Locatelli F, Medin C, Krajewska M, et al. The changing epidemiology of hepatitis C virus (HCV) infection in hemodialysis: European multicenter study. Nephrol Dial Transplant 2004; 19(4): 904-9.

Hinrichsen G, Leimenstoll G, Stegen G, Schrader H, Folsch UR, Schmidt WE for the PHV study group. Prevalence and risk factors of hepatitis C virus in; 51fection in haemodialysis patients: a multicenter study in 2796 patients. Gut 2002: 429-33.

Tokars JI, Frank M, Alter MJ, Arduino MJ. National surveillance of dialysis-associated diseases in the United States. Semin Dial 2000; 15: 162-71.

Espinosa M, Martin-Molo A, Ojeda R. Marked reduction in the prevalence of hepatitis C virus infection in haemodialysis patients: causes and consequences. Am J Kidney Dis 2004; 43: 685-9.

Al-Hilli HAA, Ghadhbam JM. Prevalence of serological markers of hepatitis B (HBsAg) and hepatitis C virus (HCV) Ab among blood donors and certain risk groups. J Fac Med Baghdad 2000; 42: 45-52.

Mohammad DS, Jawad AM. Prevalence of hepatitis markers in patients with hereditary bleeding disorders. J Fac Med Baghdad 2000; 42: 58-63.

Kadir MA, Ismail A, Tahir SS. Seropositivity of hepatitis B and C among different groups of population in Al-Tameem province. Iraqi J Comm Med 2001; 14: 21-4.

Al-Charmockly H, Mahdi JK. The prevalence of hepatitis B and C serological markers among patients with hereditary coagulation disorders. J Fac Med Baghdad 2002; 44:4-9.

Majeed MN. Prevalence of hepatitis B and C infections among thalassaemic children in Najaf city. Kufa Med J 2002; 5: 192-6.

Al- Mashshhhadani JI. Hepatitis C virus infection among haemodialysis patients in Al-Anbar governorate. Iraqi J Comm Med 2006; 20(1): 20-4.

Al-Kubaisy WA, Al- Naib KT, Habib MA. Seroprevalence of hepatitis C virus specific antibodies among Iraqi children with thalassaemia. East Mediterr Health J 2006; 12(1/2): 204-10.

Al-Kubaisy WA, Al- Naib KT, Habib MA. Prevalence of HCV/HIV co-infection among haemophilia patients in Baghdad. East Mediterr Health J 2006; 12( ¾): 264-9.

Al-Mashhadani JI, Al-Hadithi TS, Al-Diwan JK, Omer AR. Prevalence of Hepatitis C virus antibodies among health care workers in Baghdad, Iraq. JABMS 2008; 9(1):5-9.

Toffik KA, Al-Diwan JK, Al-Hadithi TS, Al-Waiz MA, OmarAR. Prevalence of the serological markers of Hepatitis B, C, and D among patients with sexually transmitted diseases (STDS) in Baghdad, Iraq. JABMS 2006; 8(1): 109-5.

Khattab OS. Prevalence and risk factors for hepatitis C virus infection in hemodialysis patients in an Iraqi renal transplant center. Saudi J Kidney Dis Transpl 2008; 19( 1): 110-5.

Farage KR. The prevalence of hepatitis C virus antibody among blood donors in Sulaimani City. Higher Diploma dissertation: College of Medicine ,University Of Sulaimani. Iraq; 2007.

Hussein AH. Seroprevalence of hepatitis B and C viruses among blood donors in Sulaimani major blood bank for the years 2006-2007: A comparative study. JZS 2010 “In press”.

Mohammed OM. Prevalence of hepatitis B and hepatitis C among blood donors in Sulaimani City. JZS 2006; 9(1)part A: 115-24.

Rahma S, Rasheed JA, Kassrow E. Prevalence of hepatitis C among multitransfused thalassemic children in Sulaimani.IPMJ 2005; 4( 2): 167-70.

Jabiar IS. Prevalence of hepatitis C antibodies in haemodialysis patients in Baghdad. MSc. Thesis, College of Medicine, Baghdad. MSc thesis, College of Medicine, Baghdad University. Iraq;

Alavian SM, Einollahi B, Hajarizadeh B, Bakhtiari S, Nafar M, Ahrabi M. Prevalence of hepatitis C virus infection and related risk fsctors among patients on hemodialysis. Nephrology 2003; 8: 256-60.

El- Shahat Y, Varma S, Bari MZ. Hepatitis C virus infection among dialysis in United Arab Emirates. Saudi J Kidney Transplant 1995; 6: 157-62.

Abboud O, Rashid A, Al-Kaabi S. Hepatitis C virus infection in haemodialysis patients in Qatar. Saudi J Kidney Dis Transplant 1995;6:151-3.

Mendez Chacon P, Vidalon A, Vidosola H. Risk factors for hepatitis C in hemodialysis and its impact on the waiting list for kidney transplantation. Rev Gastroenterol Peru 2005; 25(1): 12-8.

El-Reshaid K, Kapoor M, Saugathan T. Hepatitis C virus infection in patients on maintaince dialysis in Kuwait: epidemiological profile and efficacy of prophylaxis. Saudi J Kidney Dis Transplant 1995; 6: 144-50.

Al-Shohaib S, Abedeland MA, Zawawi T. Prevalence of hepatitis C virus antibodies among dialysis patients in Jeddah area, Saudi Arabia. Saudi J Kidney Dis Transplant 1995; 6: 128-31.

Zelia Baldessar M, Bettiol J, Foppa F, das Chagas Oliveira LH. Hepatitis C risk factors for patients submitted to dialysis. Braz J infect Dis 2007; 11( 1):

Ayoola BA, Huraib S, Arif M. Prevalence of and significance of antibodies to hepatitis C virus among Saudi haemodialysis patients. J Med Virol 1991; 35: 155-8.

Fakunla Y, Al-Mofarreh M, El Karamany WM, Ezzat HO, Al Shora B, El-Drees AZ. Prevalence of antibodies to hepatitis C virus in haemodialysis patients in Riyadh. Ann Saudi Med 1991; 11(5): 505-6.

Suliman SM, Fessaha S, El Sadiq M. Prevalence of hepatitis C virus infection in haemodialysis patients in Sudan. Saudi J Kidney Dis Transplant 1995; 6: 154-6.

Downloads

Published

2018-10-29

How to Cite

Ramzi, Z. S., Abdulla, A. A., AL-Hadithi, T., & Al-Tawil, N. G. (2018). Prevalence and Risk Factors for Hepatitis C Virus Infection in Hemodialysis Pateints in Sulaimani. Zanco Journal of Medical Sciences (Zanco J Med Sci), 14(1 Special), 44–50. Retrieved from https://zjms.hmu.edu.krd/index.php/zjms/article/view/491

Issue

Vol. 14 No. 1 Special (2010)

Section

Original Articles

License

The copyright on any article published in Zanco J Med Sci is retained by the author(s) in agreement with the Creative Commons Attribution Non-Commercial ShareAlike License (CC BY-NC-SA 4.0).